Allogene Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 30.15 M | $62.71 M | 57.91% | 9.17% |
| STATE STREET CORP | 09/22/2026 | 19.03 M | $39.57 M | 119.69% | 7.92% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 22.45 M | $46.69 M | 491.22% | 6.82% |
| PFIZER INC | 08/13/2026 | 22.03 M | $46.93 M | 0.00% | 6.70% |
| TPG GP A, LLC | 08/14/2026 | 18.72 M | $38.93 M | 0.00% | 5.69% |
| SIO CAPITAL MANAGEMENT, LLC | 08/14/2026 | 13.32 M | $27.71 M | 100.00% | 4.05% |
| PRIMECAP MANAGEMENT CO/CA/ | 08/14/2026 | 13.12 M | $27.30 M | 56.61% | 3.99% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 12.17 M | $25.31 M | 75.78% | 3.70% |
| FMR LLC | 08/13/2026 | 12.01 M | $24.98 M | 655.37% | 3.65% |
| CITADEL ADVISORS LLC | 09/02/2026 | 10.09 M | $20.98 M | 48.49% | 3.07% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 7.78 M | $16.19 M | 44.81% | 2.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 7.05 M | $14.67 M | 70.93% | 2.14% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 6.15 M | $12.79 M | 122.29% | 1.87% |
| GORDONMD GLOBAL INVESTMENTS LP | 08/14/2026 | 5.30 M | $11.02 M | 270.49% | 1.61% |
| MARSHALL WACE, LLP | 08/13/2026 | 5.10 M | $10.60 M | 47.78% | 1.55% |
| PATIENT SQUARE CAPITAL LP | 08/12/2026 | 5.05 M | $10.50 M | 46.38% | 1.54% |
| ABRDN PLC | 07/31/2026 | 5.00 M | $10.40 M | 242.07% | 1.52% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 4.84 M | $10.08 M | 45.81% | 1.47% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 4.71 M | $9.80 M | 70.45% | 1.43% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 4.64 M | $9.65 M | -13.78% | 1.41% |
| MORGAN STANLEY | 08/13/2026 | 4.51 M | $9.38 M | 351.52% | 1.37% |
| WOODLINE PARTNERS LP | 08/14/2026 | 4.50 M | $9.36 M | 28.55% | 1.37% |
| CANDRIAM S.C.A. | 08/13/2026 | 4.34 M | $9.01 M | 44.67% | 1.32% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 4.21 M | $8.76 M | 148.63% | 1.28% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 3.83 M | $7.98 M | 79.23% | 1.17% |
| HRT FINANCIAL LP | 08/14/2026 | 3.62 M | $7.53 M | 18,372.73% | 1.10% |
| WALLEYE CAPITAL LLC | 08/03/2026 | 3.27 M | $6.80 M | 100.00% | 0.99% |
| RTW INVESTMENTS, LP | 08/14/2026 | 3.25 M | $6.76 M | 100.00% | 0.99% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 3.24 M | $6.74 M | 169.55% | 0.98% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 3.19 M | $6.63 M | 49.33% | 0.97% |
| UBS GROUP AG | 08/13/2026 | 3.04 M | $6.32 M | 89.42% | 0.92% |
| GHISALLO CAPITAL MANAGEMENT LLC | 08/14/2026 | 3.00 M | $6.24 M | 100.00% | 0.91% |
| NORTHERN TRUST CORP | 08/13/2026 | 2.96 M | $6.15 M | 129.86% | 0.90% |
| WILDCAT CAPITAL MANAGEMENT, LLC | 07/22/2026 | 2.92 M | $6.08 M | 0.00% | 0.89% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 2.27 M | $4.73 M | 62.86% | 0.69% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 2.27 M | $4.73 M | 100.00% | 0.69% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 2.01 M | $4.17 M | -19.26% | 0.61% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 2.00 M | $4.16 M | 45.97% | 0.61% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.84 M | $3.82 M | 68.38% | 0.56% |
| BOXER CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.50 M | $3.12 M | -44.95% | 0.46% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2026 | 1.46 M | $3.03 M | -27.73% | 0.44% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.44 M | $3.19 M | 0.26% | 0.44% |
| RAIFFEISEN BANK INTERNATIONAL AG | 08/03/2026 | 1.10 M | $2.44 M | 57.14% | 0.33% |
| INVESCO LTD. | 08/14/2026 | 772.79 K | $1.61 M | 12.89% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 727.18 K | $1.51 M | 84.01% | 0.22% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 07/08/2026 | 722.93 K | $1.50 M | 100.00% | 0.22% |
| MAN GROUP PLC | 08/14/2026 | 701.90 K | $1.46 M | 353.77% | 0.21% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 678.97 K | $1.41 M | 100.00% | 0.21% |
| NUVEEN, LLC | 08/11/2026 | 624.65 K | $1.30 M | -73.02% | 0.19% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 09/09/2026 | 426.27 K | $886.65 K | -34.84% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Allogene Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 284 institutional investors and hedge funds held shares of Allogene Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 30.15 M
Frazier Life Sciences Management, L.P.: 22.45 M
PFIZER INC: 22.03 M
STATE STREET CORP: 19.03 M
TPG GP A, LLC: 18.72 M
Sio Capital Management, LLC: 13.32 M
95.75% of Allogene Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 368.55 M shares in the last 24 months. This purchase volume represents approximately $921.38 M in transactions.